AML classification in the year 2023: How to avoid a Babylonian confusion of languagesAcute myeloid leukaemiaIn parallel to the 5th edition of the World Health Organization Classification of Haematolymphoid Tumours (WHO 2022), an alternative International Consensus Classification (ICC) has been proposed....
因此,耶鲁大学Amer M Zeidan博士等研究者,在《Lancet Haematol》杂志发表题为“Standardising acute myeloid leukaemia classification systems: a perspective from a panel of international experts”的重磅综述回顾了这两个分类系统的优点和局限性(尤其是...
2. 附加于上述AML的诊断限定词 参考文献:Shallis RM, Daver N, Altman JK, et al. Standardising acute myeloid leukaemia classification systems: a perspective from a panel of international experts. Lancet Haematol. 2023;10(9):e767-e776. doi:10.1016/S2352-3026(23)001...
There are 2 staging systems that are commonly used during diagnosis of acute myeloid leukemia (AML). The French-American-British (FAB) classification system is based on morphology to define specific immunotypes.
最近笔者读了一篇题为"Controversies in the recent (2016) World Health Organization classification of acute myeloid leukemia"的文章。 文章阐述了世界卫生组织(WHO)分类中一些值得探讨的问题,不管是知识的更新,还是学习用于工作上指导骨髓形态学诊断都有一定意义。
出处 《诊断学理论与实践》 2023年第5期421-428,共8页 Journal of Diagnostics Concepts & Practice 关键词 第5版WHO造血和淋巴肿瘤分类 骨髓增生异常肿瘤 急性髓系白血病 5th edition of the WHO Classification of Haematolymphoid Tumours Myelodysplastic neoplasms Acute myeloid leukemia 分类号 R735.3 [医药卫...
which may limit its use in resource-poor environments (Asimomitis et al.2023). The integration of scRNA-seq with molecular genetics and flow cytometry, could further increase the precision of classification and hence AML patient-specific treatment strategies. This study also discussed the value of ...
TP53 status and impact on AML prognosis within the ELN 2022 risk classification. Blood. 2023;142(23):2029–33. Article CAS PubMed Google Scholar Stein EM. IDH2 inhibition in AML. Blood. 2023;141(2):124–5. Article CAS PubMed Google Scholar Chaturvedi A, Araujo Cruz MM, Jyotsana N...
which may limit its use in resource-poor environments (Asimomitis et al.2023). The integration of scRNA-seq with molecular genetics and flow cytometry, could further increase the precision of classification and hence AML patient-specific treatment strategies. This study also discussed the value of ...
Journal of Hematology & Oncology volume 16, Article number: 96 (2023) Cite this article 3715 Accesses 9 Citations 17 Altmetric Metrics details Abstract Background About half of AML patients achieving complete remission (CR) display measurable residual disease (MRD) and eventually relapse. FLYSYN ...